D Van Nostrand

Summary

Country: USA

Publications

  1. doi request reprint Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer
    D Van Nostrand
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center and Professor of Medicine, Georgetown University School of Medicine, Washington, DC 20010, USA
    Oral Dis 17:154-61. 2011
  2. doi request reprint Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, Washington, DC 20010, USA
    J Nucl Med 53:359-62. 2012
  3. doi request reprint Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, 110 Irving Street NW, Washington, DC 2001, USA
    Thyroid 20:1113-9. 2010
  4. doi request reprint (124)I positron emission tomography versus (131)I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well-differentiated thyroid cancer
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, Washington, DC 20010, USA
    Thyroid 20:879-83. 2010
  5. doi request reprint The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer
    Douglas Van Nostrand
    Division of Nuclear Medicine, and Nuclear Medicine Residency Program, Washington Hospital Center, Washington, District of Columbia, USA
    Thyroid 19:1381-91. 2009
  6. doi request reprint Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma
    Douglas Van Nostrand
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center, Washington, District of Columbia 20010, USA
    Thyroid 19:1093-8. 2009
  7. doi request reprint Salivary gland protection with sialagogues: a case study
    Douglas Van Nostrand
    Division Nuclear Medicine, Washington Hospital Center, Washington, District of Columbia 20010, USA
    Thyroid 19:1005-8. 2009
  8. doi request reprint The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer
    Douglas Van Nostrand
    Department of Medicine, Washington Hospital Center, District of Columbia 20010, USA
    Thyroid 19:849-55. 2009
  9. ncbi request reprint Radioiodine in the treatment of thyroid cancer
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, and Georgetown University Medical Center, Washington, DC 20010, USA
    Endocrinol Metab Clin North Am 36:807-22, vii-viii. 2007
  10. doi request reprint Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer
    Laura Seiboth
    Endocrine Medicine Section, Washington Hospital Center, Georgetown University Medical Center, Washington, DC 20010, USA
    Thyroid 18:103-11. 2008

Collaborators

Detail Information

Publications21

  1. doi request reprint Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer
    D Van Nostrand
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center and Professor of Medicine, Georgetown University School of Medicine, Washington, DC 20010, USA
    Oral Dis 17:154-61. 2011
    ....
  2. doi request reprint Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, Washington, DC 20010, USA
    J Nucl Med 53:359-62. 2012
    ..The objective of this study was to evaluate these 2 methods of patient preparation for the detection of metastases from differentiated thyroid cancer (DTC) using (131)I WB imaging and (124)I PET...
  3. doi request reprint Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, 110 Irving Street NW, Washington, DC 2001, USA
    Thyroid 20:1113-9. 2010
    ..To evaluate this we measured the radiopharmacokinetics of ¹²³I in the parotid glands (PGs) after its administration of lemon juice (LJ)...
  4. doi request reprint (124)I positron emission tomography versus (131)I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well-differentiated thyroid cancer
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, Washington, DC 20010, USA
    Thyroid 20:879-83. 2010
    ..The objective of this study was to compare the ability of diagnostic (124)I PET images versus (131)I planar whole-body imaging in detecting residual thyroid tissue and/or metastatic well-differentiated thyroid cancer (WDTC)...
  5. doi request reprint The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer
    Douglas Van Nostrand
    Division of Nuclear Medicine, and Nuclear Medicine Residency Program, Washington Hospital Center, Washington, District of Columbia, USA
    Thyroid 19:1381-91. 2009
    ..This in turn helps the treating physician and patient in making decisions regarding therapy...
  6. doi request reprint Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma
    Douglas Van Nostrand
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center, Washington, District of Columbia 20010, USA
    Thyroid 19:1093-8. 2009
    ..in 2003 for increasing or decreasing activity, and to determine the relationship between %WBR(48hr) and maximum tolerated activity (MTA)...
  7. doi request reprint Salivary gland protection with sialagogues: a case study
    Douglas Van Nostrand
    Division Nuclear Medicine, Washington Hospital Center, Washington, District of Columbia 20010, USA
    Thyroid 19:1005-8. 2009
    ..One proposed mechanism is that sialagogues increased salivation and salivary blood flow resulting in greater radioiodine uptake in the salivary glands-a rebound effect. This case study demonstrates no rebound effect...
  8. doi request reprint The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer
    Douglas Van Nostrand
    Department of Medicine, Washington Hospital Center, District of Columbia 20010, USA
    Thyroid 19:849-55. 2009
    ..The utility of radioiodine (RAI) scans prior to (131)I ablation is controversial. The objective of this study was to evaluate the utility of RAI scans prior to (131)I ablation in patient with well-differentiated thyroid cancer...
  9. ncbi request reprint Radioiodine in the treatment of thyroid cancer
    Douglas Van Nostrand
    Division of Nuclear Medicine, Washington Hospital Center, and Georgetown University Medical Center, Washington, DC 20010, USA
    Endocrinol Metab Clin North Am 36:807-22, vii-viii. 2007
    ....
  10. doi request reprint Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer
    Laura Seiboth
    Endocrine Medicine Section, Washington Hospital Center, Georgetown University Medical Center, Washington, DC 20010, USA
    Thyroid 18:103-11. 2008
    ..We define standard imaging as a neck sonogram, 131I scan, computed tomography, and MRI...
  11. ncbi request reprint Integrating fine-needle aspiration into a daily practice involving thyroid disorders: the Washington Hospital Center approach
    Yolanda C Oertel
    Department of Pathology, Washington Hospital Center, Washington, D C 20010 2975, USA
    Diagn Cytopathol 27:120-2. 2002
  12. ncbi request reprint Benzodiazepine-resistant "brown fat" pattern in positron emission tomography: two case reports of resolution with temperature control
    Carlos A Garcia
    Division of Nuclear Medicine, Washington Hospital Center, Washington, DC 20010, USA
    Mol Imaging Biol 6:368-72. 2004
    ..To our knowledge, no case reports or studies have been published to demonstrate whether controlling the temperature can alter the physiological uptake in these regions...
  13. ncbi request reprint Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan
    Carlos A Garcia
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center, 110 Irving Street, NW, Washington, DC 20010, USA
    Mol Imaging Biol 8:24-9. 2006
    ..As an alternative, we evaluated the effect of controlling the patient's environmental temperature on brown fat uptake of FDG...
  14. doi request reprint Effective reduction of brown fat FDG uptake by controlling environmental temperature prior to PET scan: an expanded case series
    Carlos Garcia
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center, 110 Irving St NW, Washington, DC 20010, USA
    Mol Imaging Biol 12:652-6. 2010
    ..Previously, Garcia et al. demonstrated in ten patients a significant decrease in brown fat uptake of 2-deoxy-2-[F-18]fluoro-D: -glucose (FDG) after controlling the patient's environmental temperature...
  15. ncbi request reprint (18)F-FDG PET hemispheric cerebral hypometabolic activity: patient motion artifact
    Carlos A Garcia
    Department of Nuclear Medicine, Washington Hospital Center, Washington, District of Columbia 20010, USA
    J Nucl Med Technol 34:86-7. 2006
    ..Non-attenuation correction images demonstrated a patient motion artifact attributable to lateral movement of the patient's head during image acquisition. Subsequent repeat (18)F-FDG PET showed normal cerebral cortical activity...
  16. ncbi request reprint Overt and 'subclinical' hypothyroidism in women
    Leonard Wartofsky
    Uniformed Services University, Bethesda, Maryland, USA
    Obstet Gynecol Surv 61:535-42. 2006
    ....
  17. ncbi request reprint Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma
    Douglas Van Nostrand
    Department of Medicine, Washington Hospital Center, Washington, DC 20010, USA
    Thyroid 12:121-34. 2002
    ..This review does not address use of dosimetrically-determined doses of radioiodine for the initial ablation of thyroid tissue postoperatively...
  18. ncbi request reprint The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer
    K Kulkarni
    Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center, Washington, DC 20010, USA
    Thyroid 16:1019-23. 2006
    ....
  19. doi request reprint Salivary gland malignancy and radioiodine therapy for thyroid cancer
    Joanna Klubo-Gwiezdzinska
    Department of Medicine, Washington Hospital Center, Washington, DC 20010 2910, USA
    Thyroid 20:647-51. 2010
    ..RAI residency within salivary tissues is known to have both acute and chronic consequences on salivary function, but secondary neoplasia is quite unusual...
  20. doi request reprint Metastases of well-differentiated thyroid cancer to the gastrointestinal system
    Joanna Klubo-Gwiezdzinska
    Department of Medicine, Washington Hospital Center, Washington, DC, USA
    Thyroid 20:381-7. 2010
    ..Of all sites for distant metastasis, gastrointestinal metastases of thyroid cancer are very uncommon and account for 0.5-1% of all distant metastases...
  21. ncbi request reprint Rare case of double inlet left ventricle: functional and anatomic information provided by adenosine Tc-99m sestamibi SPECT
    Benjamin Kleiber
    Department of Cardiology, Washington Hospital Center, Washington, DC 20010, USA
    J Nucl Cardiol 13:e9-11. 2006